Several possible studies
Story checked
Binghamton University scientists win seed funding for medical technologies (opens in a new tab)
news-medical.net · 2026-09-22
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Binghamton University scientists win seed funding for medical technologies
news-medical.net · 2026-09-22
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedTwo Binghamton University faculty members will receive seed funding through the SUNY Technology Accelerator Fund, which provides grants to faculty inventors and scientists.View evidenceHide evidence
As statedseed funding
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedOne funded project, ClinSegAI from Nancy Guo, uses artificial intelligence to detect biomarkers within standard pathology imaging to rapidly reduce treatment decision time and may improve the standard of care.View evidenceHide evidence
As statedrapidly reduce treatment decision time
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedGuo said the medical imaging analysis model will incorporate molecular biology insights to identify early indicators of tumor progression, potentially detecting changes before they are visible through conventional radiological assessment.View evidenceHide evidence
As statedbefore they are visible through conventional radiological assessment
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedAnother funded project, led by John Fetse, is researching RNA therapeutics and aims to improve lipid nanoparticle delivery by incorporating amino acids directly into the lipids, reducing toxicity risk and improving delivery rates.View evidenceHide evidence
As statedimproving delivery rates
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedFetse said the technology, PeptoLNP, is built from amino acids, is naturally biodegradable and adaptable for targeting different tissues, and is intended to move from the lab toward patients.View evidenceHide evidence
As statedtoward patients
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Europe PMC, Crossref · 15 candidate papers
Artificial intelligence-assisted type 2 inflammatory endotyping in CRSwNP: from Sinus CT and digital pathology to biologic decision support.
Frontiers in Allergy · 2026 · PubMed, Europe PMC
Generative artificial intelligence technologies in pathology
Advances in Digital Pathology and Artificial Intelligence in Pathology · 2027 · Crossref
Spatial immune biomarkers in triple-negative breast cancer: emerging evidence, technology trade-offs, and barriers to clinical translation.
Frontiers in Immunology · 2026 · PubMed
Regulations and ethical considerations in digital pathology and artificial intelligence
Advances in Digital Pathology and Artificial Intelligence in Pathology · 2027 · Crossref
Promise and pragmatism of AI in global-scale digital pathology: pan-cancer approaches for clinical practice.
2026 · Europe PMC
And 10 more candidates considered.